Abstract:Extracellular micro- and nanoscale membrane vesicles produced by different cells progressively attract the attention of the scientific community. They function as mediators of intercellular communication and transport genetic material and signaling molecules between the cells. In the context of keeping homeostasis, the extracellular vesicles contribute to the regulation of various systemic and local processes. Vesicles released by the tumor and activated stromal cells exhibit multiple functions including support of tumor growth, preparation of the pre-metastatic niches, and immune suppression. Considerable progress has been made regarding the criteria of classification of the vesicles according to their origin, content, and function: Exosomes, microvesicles, also referred to as microparticles or ectosomes, and large oncosomes were defined as actively released vesicles. Additionally, apoptotic bodies represented by a highly heterogeneous population of particles produced during apoptosis, the programmed cell death, should be considered. Because the majority of isolation techniques do not allow the separation of different types of vesicles, a joined term "extracellular vesicles" (EVs) was recommended by the ISEV community for the definition of vesicles isolated from either the cell culture supernatants or the body fluids. Because EV content reflects the content of the cell of origin, multiple studies on EVs from body fluids in the context of cancer diagnosis, prediction, and prognosis were performed, actively supporting their high potential as a biomarker source. Here, we review the leading achievements in EV analysis from body fluids, defined as EV-based liquid biopsy, and provide an overview of the main EV constituents: EV surface proteins, intravesicular soluble proteins, EV RNA including mRNA and miRNA, and EV DNA as potential biomarkers. Furthermore, we discuss recent developments in technology for quantitative EV analysis in the clinical setting and future perspectives toward miniaturized high-precision liquid biopsy approaches.

Small extracellular vesicles: Multi-functional aspects in non-small cell lung carcinoma

Unraveling the Connection: Extracellular Vesicles and Non-Small Cell Lung Cancer

Extracellular vesicles in non-small cell lung cancer stemness and clinical applications

Small Extracellular Vesicles: A Novel Avenue for Cancer Management

The Rise of Extracellular Vesicles as New Age Biomarkers in Cancer Diagnosis: Promises and Pitfalls

The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy

Extracellular Vesicles: Recent Developments in Technology and Perspectives for Cancer Liquid Biopsy

Extracellular Vesicles as Next-Generation Biomarkers in Lung Cancer Patients: A Case Report on Adenocarcinoma and Squamous Cell Carcinoma

Extracellular vesicles: A dive into their role in the tumor microenvironment and cancer progression

Extracellular vesicles as tools and targets in therapy for diseases

Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer

Extracellular Vesicles in Lung Cancer: Implementation in Diagnosis and Therapeutic Perspectives

Extracellular Vesicles in Colorectal Cancer: From Tumor Growth and Metastasis to Biomarkers and Nanomedications

Recent advances to address challenges in extracellular vesicle-based applications for lung cancer

The role of extracellular vesicles from different origin in the microenvironment of head and neck cancers

Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine

Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools

Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy

Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers

Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management

Extracellular Vesicles as Liquid Biopsy Biomarkers across the Cancer Journey: From Early Detection to Recurrence